Wanbury Ltd


BSE: 524212 | NSE: WANBURY | ISIN: INE107F01022 
Market Cap: [Rs.Cr.] 47 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Board Meet

30-May-13 
Audited Results 
07-Feb-13 
Quarterly Results Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2013, has approved restructuring of business by way of transferring the Formulation businesses to a subsidiary of the Company subject to the approval of the Bankers of the Company and other regulatory authorities. (As per BSE Announcement Dated on 07.02.2013) 
05-Nov-12 
Quarterly Results 
06-Aug-12 
Quarterly Results 
28-May-12 
Audited Results Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2012, inter alia, has transacted the following; - Mr. Ashok Shinkar has resigned from the position of Director of the Company. (As Per BSE Announcement Dated on 28.05.2012) 

AGM

24-Sep-12
Wanbury Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on September 24, 2012. 
27-Sep-11
Wanbury Limited has informed the Exchange that the Annual General Meeting of the Member of the Company is scheduled to be held on September 27, 2011. 
12-Aug-10
AGM 12/08/2010 Wanbury Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on August 12, 2010, inter alia, have approved to the following: 1. Audited Balance Sheet as at March 31, 2010 and Profit & Loss Account for the year ended on that date along with Reports of Directors and Auditors thereon. 2. Re-appointment of Directors, Mr. N. K. Puri and Mr. K. Chandran. 3. Re-appointment of Statutory Auditors of the Company, M/s. Kapoor and Parekh Associates, Chartered Accountant, Mumbai, to hold office from the conclusion of this Annual General Meeting until the conclusion of next Annual General Meeting. 4. Re-appointment of M/s. Brahmayya & Co., Chartered Accountant, Vijayawada, as Branch Auditors of the Company, to audit the accounts of the Company's Plant Situated at Tanaku, West Godavari, District, Andhra Pradesh, to hold office from the conclusion of this Annual General Meeting until the conclusion of next Annual General Meeting. 5. Appointment of Mr. K. Chandran as Whole Time Director of the Company w.e.f. September 01, 2010. 6. Removal of Director, Dr. Rajaram Samant. (As Per BSE Announcement Dated on 12.08.2010) 
29-Sep-09
Wanbury Limited has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 29, 2009. Wanbury Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on September 29, 2009, inter alia, have approved the following: 1. Audited Balance Sheet as at March 31, 2009 and Profit & Loss Account for the year ended on that date along with Reports of Directors and Auditors thereon. 2. Re-appointment of Director, Dr. P L Tiwari. 3. Re-appointment of Statutory Auditors of the Company, M/s. Kapoor and Parekh Associates, Chartered Accountant, Mumbai to hold office from the conclusion of this Annual Meeting General Meeting until the conclusion of next Annual General Meeting. 4. Re-Appointment of M/s. Brahmayya & Co., Chartered Accountant, Vijayawada, as Branch Auditors of the Company, to audit the accounts of the Company's Plant Situated at Tanaku, West Godavari, District, Andhra Pradesh, to hold office from the conclusion of this Annual General Meeting until the conclusion of next Annual General Meeting. 5. Appointment of Mr. Ashok Shinkar as Director as well as Whole Time Director of the Company. (As per BSE Announcement Dated on 29.09.2009) Wanbury Ltd has submitted to BSE a copy of the 21st Annual General Meeting (AGM) of the Company held on September 29, 2009. (As Per BSE Announcement Website dated on 29.10.2009) 
23-Mar-09
AGM 23/03/2009 Wanbury Ltd has informed BSE that the members at the 20th Annual General Meeting (AGM) of the Company held on March 23, 2009, inter alia, have approved the following: 1. Audited Balance Sheet as at September 30, 2008 and Profit & Loss Account for the year ended on that date along with Reports of Directors and Auditors thereon. 2. Dividend @ 5% i.e. Rs 0.50 per equity share for the financial year 2007-2008. 3. Re-appointment of Directors Mr. K R N Moorthy & Mr. A L Bongirwar. 4. Re-appointment of Statutory Auditors of the Company, M/s. Kapoor and Parekh Associates, Chartered Accountant, Mumbai to hold office from the conclusion of this Annual Meeting General Meeting until the conclusion of next Annual General Meeting. 5. Appointment of M/s. Brahmayya & Co., Chartered Accountant, Vijayawada, as Branch Auditors of the Company, to audit the accounts of the Company's Plant Situated at Tanaku, West Godavari, District, Andhra Pradesh, to hold office from the conclusion of this Annual General Meeting until the conclusion of next Annual General Meeting. (As Per BSE Announcement Website dated on 24.03.2009) 

EGM

17-Oct-06
Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 07, 2006, has approved the following: To call EGM on October 17, 2006, to approve the merger scheme of Doctors Organic Chemicals Ltd with the Company in addition the merger Scheme of the Pharamaceutical Products of India Ltd with the Company. EGM 17.10.2006 To approve the merger scheme of Doctors Organic Chemicals Ltd with the Company in addition the merger Scheme of the Pharamaceutical Products of India Ltd with the Company. (As Per BSE Bulletin Dated on 08/09/2006) Wanbury Ltd has informed BSE that an Extra Ordinary General Meeting of the members of the Company will be held on October 17, 2006, inter alia, to transact the following business: 1. To approve the draft Scheme of Merger of the Pharmaceutical Products of India Ltd with the Company, subject to the modifications permitted and the Scheme with modification as may be suggested be sent to the BIFR for its consideration and approval, subject to necessary provision and approval. 2. To issue and allot up to maximum of: i. 627,287 equity shares of Rs 10/- each at par to the Equity Shareholders of The Pharmaceutical Products of India Ltd (PPIL) whose name appear on the Register of Members of PPIL on such date as may hereafter be fixed by the Board of Directors of the Company in proportion of 2 Equity Shares of the Company for every 27 equity shares of Rs 10/- each held in PPIL; and in addition to the above-mentioned equity shares, 12,54,574 warrants of the Company to the Equity Shareholders of PPIL, whose names appear on the Register of Members of PPIL on the Record Date in proportion of 4 Warrants of the Company for every 27 equity shares of Rs 10/- each held in PPIL, subject to terms & conditions. ii. 64,668 equity shares of Rs 10/- each fully paid up at a premium of Rs 140 per share to the below mentioned Secured Creditors of PPIL as per Scheme of Arrangement approved by the Hon'ble High Court of judicature at Bombay. ARCIL : 39,923 Equity Shares IIBI :3,888 Equity Shares Unit Trust of India : 16,003 Equity Shares Bank of India : 1,382 Equity Shares Bank of Baroda : 2,951 Equity Shares Union Bank of India : 521 Equity Shares iii. 58,200 Zero Coupon Optionally Fully Convertible Debentures (OFCDs) having face value of Rs 1000/- each to the below mentioned Secured Creditors of PPIL as per Scheme of Arrangement approved by the Hon'ble High Court of judicature at Bombay, on terms & conditions. ARCIL : 35,930 Equity Shares IIBI : 3,499 Equity Shares UTI : 14,402 Equity Shares BOI : 1,244 Equity Shares BOB : 2,656 Equity Shares UBI : 469 Equity Shares 3. To approve the draft Scheme of Merger of Doctors Organic Chemicals Ltd with the Company, subject to the modifications permitted and the Scheme with modification as may be suggested be sent to the BIFR for its consideration and approval, subject to necessary provision and approval. 4. To issue and allot up to maximum of 4,69,141 equity shares of Rs 10/- each at par to the Equity Shareholders of Doctors Organic Chemicals Ltd, whose name appear on the Register of Members of Doctors Organic Chemicals Ltd on such date as may hereafter be fixed by the Board of Directors of the Company in proportion of 1 Equity Share of the Company for every 6 equity shares of Rs 10/- each held in Doctors Organic Chemicals Ltd, subject to necessary approval and provisions. (As per BSE Announcement website dated on 29/09/2006) Wanbury Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on October 17, 2006, have approved the following: 1. The Scheme of Merger of the Pharmaceutical Products of India Ltd with the Company. 2. The Board of Directors of the Company has been authorized to issue and allot Equity Shares & Warrants of the Company to the Members of the Pharmaceutical Products of India Ltd (PPIL) and Equity Shares & OFCDs of the Company to the Secured Creditors of the Pharmaceutical Products of India Ltd. 3. The Scheme of Merger of Doctors Organic Chemicals Ltd with the Company. 4. The Board of Directors of the Company has been authorized to issue and allot Equity Shares of the Company to the Members of Doctors Organic Chemicals Ltd. (As per BSE Announcement website dated on 17/10/2006) 
10-Sep-04
The company has informed that at the EGM held on 10-09-04, members have unanimoously passed the resolution for Change of nameof the company from Pearl Organics Ltd. to Wanbury Ltd. 
30-Apr-04
EGM 30/04/2004 To approve the Scheme of Amalgamation of Wander Pvt. Ltd., with the company. 
07-Feb-03
In the EGM of the company held on 07.02.2003, the members of the company have approved and authorized Board of Directors of the company by majority for proposed allotment of 3700000 equity shares of Rs 10/- each of the company to Wander Pvt Ltd on preferential allotment basis. The allotment of equity shares is being made for acquistion of the Setcal brand from Wander Pvt Ltd for Rs 370.00 Lacs being the total consideration for the brand acquistion.  

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 36,002.25 28.56 7.43 21.23 23.4 22.7 0.30
Divi's Lab. 14,883.27 23.10 6.84 13.41 27.3 34.1 0.02
Jubilant Life 2,530.48 32.16 1.36 21.18 3.1 6.4 1.43
Shilpa Medicare 698.99 13.96 2.39 9.34 16.3 18.0 0.19
Hikal 673.22 26.39 1.96 5.65 22.4 18.2 1.53
Elder Pharma 658.20 7.15 0.85 6.59 12.9 13.0 1.25
Dishman Pharma. 585.08 12.08 0.87 5.44 6.8 10.2 0.80
Vinati Organics 544.08 7.93 2.26 5.63 33.2 31.3 0.75
Shasun Pharma. 455.06 16.51 1.68 7.48 14.0 8.9 1.05
Orchid Chemicals 443.84 0.00 0.48 7.67 9.7 8.3 1.75
Nectar Lifesci. 402.84 4.70 0.46 6.25 9.7 11.2 1.22
Sequent Scien. 360.72 0.00 2.36 7.62 -3.9 5.9 1.58
Suven Life Scie. 310.69 10.08 2.01 10.21 11.3 9.1 0.64
Granules India 289.67 9.60 1.07 4.12 11.7 15.2 0.57
Aarti Drugs 254.49 5.59 1.23 4.78 13.5 13.7 1.48

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

A L Bongirwar , Director 

N K Puri , Director 

P L Tiwari , Director 

P R Dalal , Nominee (EXIM) 


Company Head Office / Quarters:
BSEL Tech Park B-Wing 10th Flr,
Sector 30 A Opp Vashi Rly Stat,
Navi Mumbai,
Maharashtra-400705
Phone : 91-22-67942222
Fax : 91-22-67942111/333
E-mail : shares@wanbury.com
Web : http://www.wanbury.com
Registrars:
Sharex Dynamic (India) Pvt Ltd
Unit No 1 Luthra Ind
Andheri Kurla Road
Safed Pool Andheri(E
Mumbai - 400 072

Fund Holding

 
Scheme Name No. of Shares
UTI-Unit Linked Insurance Plan 10,002

Calendar

May-2013
M T W T F S S
13 14 15 16 17 18 19
IPO
listIssue Open : Onesource Techm.
Economic Events
list Rightmove House Prices (MoM)
list Performance Services Index
Results
list No result today